Catherine S. Spina

SCCA1/SERPINB3 promotes suppressive immune environment via STAT-dependent chemokine production, blunting the therapy-induced T cell responses

P. Grigsby, J. Schwarz, P. Cosper, 2023, bioRxiv.

SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production

P. Grigsby, Subhajit Ghosh, J. Schwarz, 2023, The Journal of clinical investigation.

KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response

C. Drake, Somnath Tagore, S. Bansal, 2023, Journal for immunotherapy of cancer.

KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response

C. Drake, Somnath Tagore, S. Bansal, 2023, Journal for ImmunoTherapy of Cancer.

Preliminary efficacy of [^90Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer

J. McKiernan, A. Mintz, M. Doubrovin, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Abstract B032: Combined A2AR and PARP inhibition in homologous recombination deficient (HRD) castrate-resistant prostate cancer (CRPC)

C. Drake, S. Bansal, P. McCann, 2023, Cancer Research.